본문

  1. Home
322 Results:PP:E PP:ELSEVIER INC 0.187 sec.
RSS 
Multilingual
 การค้นหาขั้นสูง
 เดินทางมาถึงค้นหาวัสดุใหม่
พิมพ์ที่เลือก Select Export to Excel
21
Testosterone, but not IGF-1, LH, prolactin or cortisol, may serve as antler-stimulating hormone in red deer stags (Cervus elaphus)
Testosterone, but not IGF-1, LH, prolactin or cortisol, may serve as antler-stimulating hormone in red deer stags (Cervus elaphus)
Bartoš, L. k., | Elsevier Inc | 2009 ,
22
Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats
Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats
Shen, C. L., | Elsevier Inc | 2009 ,
23
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients
Tomida, K., | Elsevier Inc | 2009 ,
24
Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses
Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses
Ren, W., | Elsevier Inc | 2009 ,
25
Critical issues of PTH assays in CKD
Critical issues of PTH assays in CKD
Komaba, H., | Elsevier Inc | 2009 ,
26
Physical tests for patient selection for bone mineral density measurements in postmenopausal women
Physical tests for patient selection for bone mineral density measurements in postmenopausal women
Kärkkäinen, M., | Elsevier Inc | 2009 ,
27
Rate of proximal humeral fractures in older Finnish women between 1970 and 2007
Rate of proximal humeral fractures in older Finnish women between 1970 and 2007
Kannus, P., | Elsevier Inc | 2009 ,
28
Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis
Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis
Kawashima, Y., | Elsevier Inc | 2009 ,
29
Alendronate/vitamin D3 70 mg
Alendronate/vitamin D3 70 mg
Binkley, N., | Elsevier Inc | 2009 ,
30
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone
Zikan, V., | Elsevier Inc | 2009 ,
처음이전12345678910이후마지막